Healthcare -
Biotechnology - NASDAQ - US
$ 4.975
-2.26 %
$ 216 M
Market Cap
-2.43
P/E
ABEO - STOCK-BASED COMPENSATION
Stock-based Compensation ABEO - Abeona Therapeutics Inc.
4.77 M
LAST VALUE
-26.87%
2 YEAR CAGR
-11.67%
5 YEAR CAGR
26.94%
10 YEAR CAGR